Abstract
Here we present a case of complement-mediated thrombotic microangiopathy (TMA) in a patient who has a background of Stage 5 chronic kidney disease secondary to Alport syndrome. We explain our approach to the diagnosis of TMA, especially the reliance on non-renal manifestations of TMA and the role of kidney biopsy given there was a background of advanced kidney impairment at baseline.
Original language | English |
---|---|
Pages (from-to) | 688-690 |
Number of pages | 3 |
Journal | Nephrology |
Volume | 29 |
Issue number | 10 |
DOIs | |
Publication status | Published - 2024 |
Bibliographical note
Publisher Copyright:© 2024 The Authors. Nephrology published by John Wiley & Sons Australia, Ltd on behalf of Asian Pacific Society of Nephrology.
Keywords
- acute kidney injury
- Alport syndrome (hereditary nephritis)
- thrombotic microangiopathy